ALXO US00166B1052

Report

Delayed Nasdaq - 04:00 2022-08-05 pm EDT
11.47	USD		+5.62%

08/01	ALX Oncology Receives FDA Fast-Track Designation for Head, Neck Cancer Drug	MT
08/01	ALX Oncology's Evorpacept Receives Fast Track Designation from FDA as First-Line Treatment for Head and Neck Squamous Cell Carcinoma	GL
08/01	ALX Oncology's Evorpacept Receives Fast Track Designation from FDA as First-Line Treatment for Head and Neck Squamous Cell Carcinoma	GL

Calendar

Event chart ALX ONCOLOGY HOLDINGS INC.

Upcoming events on ALX ONCOLOGY HOLDINGS INC.

09/01/22		Interim 2022 Earnings Release (Projected)
11/17/22		Q3 2022 Earnings Release (Projected)
03/16/23		FY 2022 Earnings Release (Projected)
05/15/23		Q1 2023 Earnings Release (Projected)

Past events on ALX ONCOLOGY HOLDINGS INC.

06/14/22 \| 04:00pm		Annual General Meeting
06/08/22 \| 10:00am		Jefferies Healthcare Conference
05/09/22 \| 04:01pm		Q1 2022 Earnings Release
02/28/22 \| 07:00am		FY 2021 Earnings Release
01/11/22 \| 10:30am		JP Morgan Healthcare Conference
12/13/21 \| 08:00am		American Society of Hematology Virtual Meeting and Exposition
12/12/21 \| 06:00pm		American Society of Hematology Virtual Meeting and Exposition - Poster Numbers - 637
11/22/21 \| 10:00am		Piper Sandler Virtual Healthcare Conference
11/18/21 \| 03:00am		Jefferies London Healthcare Conference
11/16/21 \| 10:00am		Stifel Healthcare Conference

Past dividends on ALX ONCOLOGY HOLDINGS INC.

- No events available -

Annual results

Fiscal Period : December		2019	2020	2021	2022
Sales M $	Released Forecast Spread	4,80	1,18 1,11 6,2%
Operating income (EBITDA) M $	Released Forecast Spread		-43,5 -37,8 -15%	-83,5 -80,2 -4,1%	-110
Operating profit (EBIT) M $	Released Forecast Spread		-43,7 -38,0 -15%	-83,6 -80,6 -3,7%	-111
Pre-Tax Profit (EBT) M $	Released Forecast Spread		-45,5 -39,4 -16%	-83,5 -79,9 -4,5%	-108
Net income M $	Released Forecast Spread		-45,7 -41,9 -9,3%	-83,5 -79,9 -4,5%	-110
EPS $	Released Forecast Spread	-1,15	-2,76 -1,87 -48%	-2,07 -1,97 -5,2%	-2,70
Announcement Date		05/05/2020	03/18/2021	02/28/2022	-

Quarterly results

Fiscal Period : December

2021 Q1

2021 Q2

2021 Q3

2021 Q4

2022 Q1

2022 Q2

Sales
M $

Released
Forecast
Spread

0,16

0,13

Operating income
(EBITDA)
M $

Released
Forecast
Spread

-22,7

Operating profit
(EBIT)
M $

Released
Forecast
Spread

-14,2
-17,3
18%

-16,3
-18,7
13%

-24,6
-20,9
-18%

-28,5
-26,7
-6,8%

-24,7
-31,0
20%

-26,1

Pre-Tax Profit
(EBT)
M $

Released
Forecast
Spread

-14,2
-19,1
26%

-16,3
-17,4
6,6%

-24,6
-18,6
-32%

-28,5
-25,6
-11%

-24,5
-31,1
21%

-26,4

Net income
M $

Released
Forecast
Spread

-14,2
-19,1
26%

-16,3
-17,2
5,3%

-24,6
-19,1
-29%

-28,4
-25,6
-11%

-24,5
-31,0
21%

-26,7

EPS
$

Released
Forecast
Spread

-0,35
-0,44
20%

-0,40
-0,46
13%

-0,61
-0,51
-19%

-0,70
-0,62
-13%

-0,60
-0,71
16%

-0,63

Announcement Date

05/17/2021

08/12/2021

11/11/2021

02/28/2022

05/09/2022

Previous year

Next Year

Upcoming sector events for ALX ONCOLOGY HOLDINGS INC.

08/08/22		BIONTECH SE : Interim 2022 Earnings Release
10/27/22		GILEAD SCIENCES, INC. : Q3 2022 Earnings Release (Projected)
11/02/22		VERTEX PHARMACEUTICALS INCORPORATED : Q3 2022 Earnings Release (Projected)
11/03/22		WUXI APPTEC CO., LTD. : Q3 2022 Earnings Release (Projected)
11/07/22		BIONTECH SE : Q3 2022 Earnings Release
11/08/22		REGENERON PHARMACEUTICALS, INC. : Q3 2022 Earnings Release (Projected)
02/01/23		VERTEX PHARMACEUTICALS INCORPORATED : FY 2022 Earnings Release (Projected)
02/07/23		GILEAD SCIENCES, INC. : FY 2022 Earnings Release (Projected)
02/09/23		REGENERON PHARMACEUTICALS, INC. : FY 2022 Earnings Release (Projected)
03/23/23		WUXI APPTEC CO., LTD. : FY 2022 Earnings Release (Projected)

More events

Past sector events for ALX ONCOLOGY HOLDINGS INC.

08/04/22 \| 04:01pm		VERTEX PHARMACEUTICALS INCORPORATED : Interim 2022 Earnings Release
08/03/22 \| 06:30am		REGENERON PHARMACEUTICALS, INC. : Interim 2022 Earnings Release
08/02/22 \| 04:02pm		GILEAD SCIENCES, INC. : Interim 2022 Earnings Release
07/26/22 \| 05:30am		WUXI APPTEC CO., LTD. : Interim 2022 Earnings Release
05/09/22 \| 06:01am		BIONTECH SE : Q1 2022 Earnings Release
05/05/22 \| 04:01pm		VERTEX PHARMACEUTICALS INCORPORATED : Q1 2022 Earnings Release
05/04/22 \| 06:30am		REGENERON PHARMACEUTICALS, INC. : Q1 2022 Earnings Release
04/28/22 \| 04:02pm		GILEAD SCIENCES, INC. : Q1 2022 Earnings Release
04/25/22 \| 05:52am		WUXI APPTEC CO., LTD. : Q1 2022 Earnings Release
03/30/22 \| 06:00am		BIONTECH SE : FY 2021 Earnings Release

More events

Net sales (Year) - Rate of surprise

EPS (Year) - Rate of surprise

Net sales (Quarter) - Rate of surprise

EPS (Quarter) - Rate of surprise